The Cancer Questions Project, Part 18: Joseph Jurcic

Dr. Joseph Jurcic specializes in the research of acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy for leukemia, and the molecular monitoring of minimal residual disease. His work focuses on the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome. He received the 2001 Louis and Allston Boyer…

The Cancer Questions Project, Part 17: Benjamin Ebert

Dr. Benjamin Ebert is remarkable for his leadership in describing the genomic landscape of adult myelodysplastic syndrome (MDS), including identifying critical new roles for ribosomal dysfunction. His laboratory discovered the molecular basis of lenalidomide activity in MDS as well as multiple myeloma. Recent studies have identified clonal hematopoiesis and its contribution to both hematologic malignancies…

The Cancer Questions Project, Part 15: Robert “Bob” Gallo

Dr Robert Gallo, a biomedical researcher, is renowned for his role in the discovery of human immunodeficiency virus (HIV) as the infectious agent responsible for AIDS and in the development of HIV blood tests. He co-founded Profectus BioSciences, Inc., a biotechnology company. Profectus develops and commercializes technologies to reduce the morbidity and mortality caused by…

The Cancer Questions Project, Part 14: Larry Norton

Dr. Larry Norton, a breast oncologist, is well-known as a leader in the development of drug treatments for breast cancer. His research has established the importance of using sequential combinations of drugs — a strategy aimed to overcome different drug sensitivities among the cells in a tumor. He has served in leadership positions in several…

The Cancer Questions Project, Part 13: Bruce Chabner

Dr Bruce Chabner has had immense experience in the discipline of cancer drug discovery and development. During his career at the National Cancer Institute, he worked as a Senior Investigator in the Laboratory of Chemical Pharmacology, Chief of the Clinical Pharmacology Branch, Director of the Clinical Oncology Program, and Director of the Division of Cancer…

The Cancer Questions Project, Part 12: Siddhartha Mukherjee

Dr. Siddhartha Mukherjee is a physician-scientist with a persistent scientific and clinical interest in acute myeloid leukemia, hematopoiesis, novel therapeutic drug development and cancer biology. He is a Pulitzer Prize-winning author of The Emperor of All Maladies: A Biography of Cancer. He has published articles in Nature, The New England Journal of Medicine, The New…

The Cancer Questions Project, Part 11: David Steensma

Dr. David Steensma specializes in care and research for myelodysplastic syndromes and leukemia. He and colleagues were the first to identify and understand the clinical implications of the clonal hematopoiesis of indeterminate potential (CHIP). He is an Associate Editor of the Journal of Clinical Oncology responsible for the “Art of Oncology” section and has more…

The Cancer Questions Project, Part 10: Renata Pasqualini

Renata Pasqualini, is the Chief, Division of Cancer Biology, Department of Radiation Oncology at Rutgers Cancer Institute and Rutgers New Jersey Medical School having previously served as Associate Director for Translational Research and Chief of the Division of Molecular Medicine at the University of New Mexico Comprehensive Cancer Center. She has published more than 200…

The Cancer Questions Project, Part 9: Ellin Berman

Ellin Berman is a board-certified medical oncologist and hematologist with a clinical and research focus on new drug development in acute and chronic leukemias, including acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML). As a member of the multidisciplinary Leukemia Disease Management Team at Memorial Sloan Kettering Cancer Center (MSKCC), she works closely with…

The Cancer Questions Project, Part 8: Seema Khan

Dr. Seema A. Khan is Professor of Surgery in the Feinberg School of Medicine at Northwestern University, and the Bluhm Family Professor of Cancer Research. She is the Co-leader of the Women’s Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center. Her research focuses on applying biomarker knowledge to improve breast cancer risk…

The Cancer Questions Project, Part 7: Kanti Rai

Kanti R. Rai, MD, is professor of medicine at The Karches Center for Oncology Research, The Feinstein Institute for Medical Research; director of the Center for Oncology and Cell Biology, Long Island Jewish Medical Center; and professor of medicine and molecular medicine at Hofstra University Northwell School of Medicine. He has been involved in diagnosing…

The Cancer Questions Project, Part 6: Wadih Arap

Wadih Arap is the Director of the Rutgers Cancer Institute of New Jersey at University Hospital and Chief, Division of Hematology/Oncology in the Department of Medicine at Rutgers New Jersey Medical School. He has served on the National Cancer Institute’s Board of Scientific Counselors, several review boards for the National Institutes of Health and the…

The Cancer Questions Project, Part 5: Mohandas Narla

Mohandas Narla, D.Sc. is Vice President for Research of New York Blood Center and has authored 340 peer-reviewed publications and 100 review articles and book chapters. His research focuses on red cell physiology and pathology; helping improve understanding of the molecular and structural basis for red cell membrane disorders, developing mechanistic insights into pathophysiology of…

The Cancer Questions Project, Part 4: Joseph Bertino

Joseph R. Bertino, MD, is University Professor of medicine and pharmacology, UMDNJ-Robert Wood Johnson Medical School and has previously served as director of the Yale Cancer Center and chair of the Molecular Pharmacology and Therapeutics Program at Memorial Sloan-Kettering. He is the author and co-author of more than 400 scientific publications and the founding editor…

The Cancer Questions Project, Part 3: Michael Caligiuri

Michael Caligiuri, a renowned physician-scientist is the President of City of Hope National Medical Center, and Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He directed The Ohio State University Comprehensive Cancer Center for 14 years prior as well as being the chief executive officer of The James Cancer Hospital and Solove Research Institute for 10…

The Cancer Questions Project, Part 2: Steven Rosen

Dr. Steven T. Rosen is the Provost, Chief Scientific Officer, Director of the Comprehensive Cancer Center and the Beckman Research Institute for the City of Hope. He also holds the Irell & Manella Cancer Center Director’s Distinguished Chair and is the current Chair of the Medical Science Committee of the Leukemia and Lymphoma Society. Dr.…